Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdullah Ely

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Viruses|August 8, 2020
Advances with RNAi-Based Therapy for Hepatitis B Virus InfectionFiona van den Berg, Shonisani Wendy Limani, Njabulo Mnyandu, et al.
Bioorganic & Medicinal Chemistry|June 8, 2013
Inhibition of hepatitis B virus replication in cultured cells and in vivo using 2'-O-guanidinopropyl modified siRNAsMusa D Marimani, Abdullah Ely, Maximilian C R Buff, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2014
Use of guanidinopropyl-modified siRNAs to silence gene expressionMaximilian C R Buff, Stefan Bernhardt, Musa D Marimani, et al.
Viruses|November 27, 2021
In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral VectorsShonisani Wendy Limani, Njabulo Mnyandu, Abdullah Ely, et al.
Viruses|August 28, 2025
Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic MiceTiffany Smith, Prashika Singh, Ridhwaanah Bhana, et al.
Scientific Reports|August 9, 2017
ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cellsTristan Scott, Buhle Moyo, Samantha Nicholson, et al.
Viruses|September 23, 2022
Hepatitis B Virus Research in South AfricaMohube B Maepa, Abdullah Ely, Anna Kramvis, et al.
Bioorganic & Medicinal Chemistry|January 24, 2012
Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virusJolanta Brzezinska, Jennifer D'Onofrio, Maximilian C R Buff, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2015
Inhibition of replication of hepatitis B virus in transgenic mice following administration of hepatotropic lipoplexes containing guanidinopropyl-modified siRNAsMusa D Marimani, Abdullah Ely, Maximilian C R Buff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 13, 2005
Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAsSergio Carmona, Abdullah Ely, Carol Crowther, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Viruses|August 8, 2020
Advances with RNAi-Based Therapy for Hepatitis B Virus InfectionFiona van den Berg, Shonisani Wendy Limani, Njabulo Mnyandu, et al.
Bioorganic & Medicinal Chemistry|June 8, 2013
Inhibition of hepatitis B virus replication in cultured cells and in vivo using 2'-O-guanidinopropyl modified siRNAsMusa D Marimani, Abdullah Ely, Maximilian C R Buff, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2014
Use of guanidinopropyl-modified siRNAs to silence gene expressionMaximilian C R Buff, Stefan Bernhardt, Musa D Marimani, et al.
Viruses|November 27, 2021
In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral VectorsShonisani Wendy Limani, Njabulo Mnyandu, Abdullah Ely, et al.
Viruses|August 28, 2025
Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic MiceTiffany Smith, Prashika Singh, Ridhwaanah Bhana, et al.
Scientific Reports|August 9, 2017
ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cellsTristan Scott, Buhle Moyo, Samantha Nicholson, et al.
Viruses|September 23, 2022
Hepatitis B Virus Research in South AfricaMohube B Maepa, Abdullah Ely, Anna Kramvis, et al.
Bioorganic & Medicinal Chemistry|January 24, 2012
Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virusJolanta Brzezinska, Jennifer D'Onofrio, Maximilian C R Buff, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2015
Inhibition of replication of hepatitis B virus in transgenic mice following administration of hepatotropic lipoplexes containing guanidinopropyl-modified siRNAsMusa D Marimani, Abdullah Ely, Maximilian C R Buff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 13, 2005
Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAsSergio Carmona, Abdullah Ely, Carol Crowther, et al.
Pageof 6